EXPECTED TREATMENT EFFECTS Sample Clauses

EXPECTED TREATMENT EFFECTS. Expected Treatment Effects Duration Bruising/Ecchymosis Up to 3 weeks Edema/Swelling Up to 2 weeks Erythema/Redness Up to 1 week Acute Pain Immediate/momentary (while energy is being delivered) - 2 hours Induration Up to 12 weeks Pruritus Up to 2 weeks Welting/Raised Areas of Edema Up to 4 weeks Skin Burn, Scarring, Change in pigmentation Up to 8 weeks Tenderness/Soreness/Pain/Sensitivity to Touch Up to 3 weeks /Muscle Twitching/Tingling/Paresthesia/Numbness Up to 5 weeks Reduced Range of Motion Up to 3 weeks Skin Peeling Up to 2 weeks Additional potential risks include: nerve injury, arterial blood spasm, change in axilla odor, and reduction of underarm hair growth. The risks from lidocaine with epinephrine may include pain and discomfort from the injections, infection at the anesthetic site, lightheadedness, nervousness, mood change, tinnitus, blurred vision, vomiting, sensations of heat, cold or numbness, tremors, seizures, or unconsciousness. Additional uncommon side effects may include bradycardia, hypotension and cardiac arrest. Allergic reactions may appear as skin rashes, swelling or anaphylaxis. Risk associated with a starch iodine test may include an allergic reaction to iodine solution or starch powder. No risks are anticipated from completion of a gravimetric sweat test or ultrasound imaging. These risks will be minimized or reduced by monitoring the subject during the treatment and observing the skin’s response to receiving the treatment. If the treatment is not tolerated, the investigator must stop administering treatment for the subject’s safety, and the subject will be followed for adverse events for 90 days. Previous clinical studies with the Ulthera® System have shown that the sensory response was tolerable from the subject’s and investigator’s perspectives. The discomfort was transient and no subject had any residual pain beyond 30 minutes.
AutoNDA by SimpleDocs

Related to EXPECTED TREATMENT EFFECTS

  • Additional Disclosures The Sweepstakes is in no way sponsored, endorsed or administered by, or associated with Facebook, Twitter, Instagram, or any other social media platform. Each Entrant releases Facebook, Twitter, Instagram, and all other social media platforms mentioned in these Official Rules from any claims, responsibility or liability relating to their participation in this Sweepstakes. Copyright/trademark/service mark infringements are not intended or implied.

  • Professional Development; Adverse Consequences of School Exclusion; Student Behavior The Board President or Superintendent, or their designees, will make reasonable efforts to provide ongoing professional development to Board members about the adverse consequences of school exclusion and justice-system involvement, effective classroom management strategies, culturally responsive discipline, appropriate and available supportive services for the promotion of student attendance and engagement, and developmentally appropriate disciplinary methods that promote positive and healthy school climates, i.e., Senate Bill 100 training topics. Board Self-Evaluation The Board will conduct periodic self-evaluations with the goal of continuous improvement. New Board Member Orientation The orientation process for newly elected or appointed Board members includes:

  • Exclusions from Confidential Information Receiving Party's obligations under this Agreement do not extend to information that is: (a) publicly known at the time of disclosure or subsequently becomes publicly known through no fault of the Receiving Party; (b) discovered or created by the Receiving Party before disclosure by Disclosing Party; (c) learned by the Receiving Party through legitimate means other than from the Disclosing Party or Disclosing Party's representatives; or (d) is disclosed by Receiving Party with Disclosing Party's prior written approval.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!